The diagnosis of antimitochondrial antibody-negative primary biliary cholangitis.

[1]  R. Poupon.  Liver alkaline phosphatase: A missing link between choleresis and biliary inflammation , 2015, Hepatology.

[2]  T. Schiano,et al.  Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  T. Schiano,et al.  Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis , 2014, European journal of gastroenterology & hepatology.

[4]  S. Hubscher.  Role of liver biopsy in autoimmune liver disease , 2014 .

[5]  B. Portmann,et al.  Inflammatory disease of the bile ducts–cholangiopathies: liver biopsy challenge and clinicopathological correlation , 2012, Histopathology.

[6]  A. Granito,et al.  Antinuclear antibodies as ancillary markers in primary biliary cirrhosis , 2012, Expert review of molecular diagnostics.

[7]  B. Portmann,et al.  10 – Diseases of the bile ducts , 2012 .

[8]  G. Hirschfield.  Diagnosis of primary biliary cirrhosis. , 2011, Best practice & research. Clinical gastroenterology.

[9]  D. Bogdanos,et al.  Disease-specific autoantibodies in primary biliary cirrhosis. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[10]  M. Manns,et al.  Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. , 2011, Journal of hepatology.

[11]  C. Selmi,et al.  Overcoming a “Probable” Diagnosis in Antimitochondrial Antibody Negative Primary Biliary Cirrhosis: Study of 100 Sera and Review of the Literature , 2012, Clinical Reviews in Allergy & Immunology.

[12]  R. Poupon.  Primary biliary cirrhosis: a 2010 update. , 2010, Journal of hepatology.

[13]  G. Hirschfield,et al.  Autoantibodies and liver disease: uses and abuses. , 2010, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[14]  D. Vergani,et al.  New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. , 2009, Clinical chemistry.

[15]  S. Stevanović,et al.  Detection of novel non-M2-related antimitochondrial antibodies in patients with anti-M2 negative primary biliary cirrhosis , 2009, Gut.

[16]  K. Batts.  Autoimmune and Chronic Cholestatic Disorders of the Liver , 2009 .

[17]  F. Lammert,et al.  EASL Clinical Practice Guidelines: management of cholestatic liver diseases. , 2009, Journal of hepatology.

[18]  K. Boberg,et al.  AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Simplified Criteria for the Diagnosis of Autoimmune Hepatitis , 2008 .

[19]  K. Lindor,et al.  GASTROENTEROLOGY CLINICS OF NORTH AMERICA Antimitochondrial Antibody – Negative Primary Biliary Cirrhosis , 2022 .

[20]  O. Klinge,et al.  Ein der chronisch-destruierenden nicht-eitrigen Cholangitis ähnliches Krankheitsbild mit antinukleären Antikörpern (Immuncholangitis)* , 1987 .

[21]  C. Selmi,et al.  Anti-mitochondrial antibody-negative primary biliary cirrhosis. , 2008, Clinics in liver disease.

[22]  D. Vergani,et al.  Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[23]  R. Chapman,et al.  Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim‐like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis , 2006, Alimentary pharmacology & therapeutics.

[24]  J. Węsierska‐Gądek,et al.  Antinuclear antibodies in primary biliary cirrhosis. , 2005, Seminars in liver disease.

[25]  A. Granito,et al.  The Western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[26]  M. Manns,et al.  Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. , 2004, Journal of hepatology.

[27]  An-Lin Ma,et al.  [Autoimmune cholangitis]. , 2004, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[28]  K. Lindor,et al.  When is liver biopsy needed in the diagnosis of primary biliary cirrhosis? , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  G. Bianchi,et al.  Characterization and Clinical Impact of Antinuclear Antibodies in Primary Biliary Cirrhosis , 2003, American Journal of Gastroenterology.

[30]  J. Pajares,et al.  Is there an optimal therapeutic regimen for antimitochondrial antibody‐negative primary biliary cirrhosis (autoimmune cholangitis)? , 2003, Alimentary pharmacology & therapeutics.

[31]  A. Tanaka,et al.  Detection of antimitochondrial autoantibodies in immunofluorescent AMA‐negative patients with primary biliary cirrhosis using recombinant autoantigens , 2001, Hepatology.

[32]  F. Vleggaar,et al.  Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant , 2001, Gut.

[33]  M. Manns,et al.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.

[34]  I. Mackay,et al.  Autoimmune cholangitis and primary biliary cirrhosis--an autoimmune enigma. , 1999, Liver.

[35]  G. Gerken,et al.  Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals , 1999, Hepatology.

[36]  K. Pritzker,et al.  Allotype immunoglobulin enhances alkaline phosphatase activity: implications for the inflammatory response. , 1998, The Journal of laboratory and clinical medicine.

[37]  O. Chazouilleres,et al.  Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: Clinical features and response to therapy , 1998, Hepatology.

[38]  K. Tsuneyama,et al.  Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies. , 2008 .

[39]  A. Larghi,et al.  Comparison of the clinical features and clinical course of antimitochondrial antibody‐positive and ‐negative primary biliary cirrhosis , 1997, Hepatology.

[40]  M. Beaugrand,et al.  Antimitochondrial antibodies in patients with chronic hepatitis C. , 2008, Liver.

[41]  K. Tsuneyama,et al.  Abnormal expression of PDC‐E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody‐negative primary biliary cirrhosis , 1995, Hepatology.

[42]  E. Dickson,et al.  Antimitochondrial antibody-negative primary biliary cirrhosis. , 1995, The American journal of gastroenterology.

[43]  P. Scheuer,et al.  Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. , 1994, Gut.

[44]  A. Dhillon,et al.  Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis , 1993, Hepatology.

[45]  M. Rowley,et al.  Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies. , 1992, Progress in liver diseases.

[46]  R. Coppel,et al.  Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. , 1989, The New England journal of medicine.

[47]  M. Kaplan,et al.  Primary biliary cirrhosis. , 1987, The New England journal of medicine.